🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.1465
-0.0135 (-8.44%)
At close: Nov 18, 2026, 4:00 PM EST
0.1485
+0.0020 (1.37%)
After-hours: Nov 18, 2026, 7:07 PM EST

Mangoceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.30.460.620.730.01-
Revenue Growth
-35.64%-25.96%-15.81%8083.16%--
Cost of Revenue
0.140.210.240.30-
Gross Profit
0.160.250.380.430-
Selling, General & Admin
3.695.935.546.3920.07
Amortization of Goodwill & Intangibles
1.961.120.72---
Operating Expenses
9.9517.848.628.5520.07
Operating Income
-9.79-17.59-8.24-8.12-1.99-0.07
Interest Expense
-0.02-0.1-0.01--0.01-0
Interest & Investment Income
---0.01--
Other Non Operating Income (Expenses)
0.03-1.56-0.45-1.1--
EBT Excluding Unusual Items
-9.78-19.26-8.71-9.21-2-0.07
Asset Writedown
-1.24-1.24----
Legal Settlements
0-0.13----
Other Unusual Items
-0.02-0.02----
Pretax Income
-11.04-20.64-8.71-9.21-2-0.07
Earnings From Continuing Operations
-11.04-20.64-8.71-9.21-2-0.07
Minority Interest in Earnings
000---
Net Income
-11.04-20.64-8.71-9.21-2-0.07
Preferred Dividends & Other Adjustments
1.181.180.8---
Net Income to Common
-12.21-21.82-9.51-9.21-2-0.07
Net Income Growth
------
Shares Outstanding (Basic)
17102111
Shares Outstanding (Diluted)
17102111
Shares Change
137.76%408.93%84.23%49.22%34.98%-
EPS (Basic)
-0.72-2.17-4.80-8.58-2.78-
EPS (Diluted)
-0.72-2.17-4.80-8.58-2.78-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.8-5.85-4.86-7-1.39-0.07
Free Cash Flow Per Share
-0.22-0.58-2.46-6.52-1.93-0.13
Gross Margin
52.94%54.91%61.70%58.99%54.26%-
Operating Margin
-3258.25%-3858.11%-1337.90%-1109.84%-22279.70%-
Profit Margin
-4065.07%-4784.65%-1543.87%-1259.40%-22352.11%-
Free Cash Flow Margin
-1264.41%-1282.89%-789.74%-957.07%-15545.59%-
EBITDA
-8.46-15.87-7.51-8.09-1.99-
D&A For EBITDA
1.331.720.730.020-
EBIT
-9.79-17.59-8.24-8.12-1.99-0.07
SEC Filings: 10-K · 10-Q